[Clinical tests on the use of ethoxzolamide in glaucoma therapy (author's transl)].
Ethoxzolamide is a potent carboxyanhydrase inhibitor, and its use in chronic glaucoma and in the acute glaucoma attack is described in the present investigation. Ethoxzolamide shows itself to be extremely well tolerated. The frequency and intensity of the side-effects is low. The electrolyte balance remains also after prolonged administration compensated. The important advantage of this drug is its low dosability. Ethoxzolamide, which was already 1958 clinically evaluated (Gordon-Posner), represents a valuable medication for conservative glaucoma therapy.
D004341:Drug Evaluation; D005016:Ethoxzolamide / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D005901:Glaucoma / Q000188:drug therapy*; D006801:Humans; D013844:Thiazoles / Q000627:therapeutic use*
D013844:Thiazoles; D005016:Ethoxzolamide
Klinische Untersuchungen zur Anwendung von Ethoxzolamid in der Glaukomtherapie.